Formulation and Delivery
Imran Vhora, M.Pharm, PhD (he/him/his)
Alliance Manager
Cytiva
Vancouver, British Columbia, Canada
Description: The complexity and diversity of RNA-LNP approaches present challenges for research and manufacturing, including access to potent ionizable lipids, a key component in lipid nanoparticles (LNPs). Cytiva offers outsourcing strategies to de-risk and accelerate the development of promising candidates for clinical evaluation and successful commercialization.
This presentation outlines how access to scalable LNP technologies and lipids, an experienced nanoparticle team, and purpose-built manufacturing facilities can fast-track development and simplify the process.